Precision Medicine

Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Thumbnail

'Wearables are irrelevant,' says technoskeptic Ezekiel Emanuel

BOSTON—“Wearables are irrelevant for what we need to do,” said Ezekiel J. Emanuel, MD, PhD, vice provost for global initiatives and chair of the department of medical ethics and health policy at the University of Pennsylvania. Emanuel spoke during the 2015 Connected Health Symposium held by Partners HealthCare.

Thumbnail

Change the incentives, says MIT Media Lab's Joichi Ito

BOSTON—Predicting the future is becoming more and more futile, said Joichi Ito, director of the MIT Media Lab, speaking at the Connected Health Symposium, held by Partners HealthCare.

Aramark grows its healthcare business

Aramark, the $15 billion provider of services in food, facilities management and uniforms, is growing its healthcare sector, with two new contracts with Kennedy Health in New Jersey and Vanderbilt University Medical Center in Tennessee, and expanded relationships two existing partners, Thomas Jefferson University Health System and the Einstein Healthcare Network, both in the Philadelphia area.

Cleveland Clinic issues Top 10 innovations for 2016

Cleveland Clinic has unveiled its 10th annual listing of the 10 most powerful medical innovations for 2016. 

Ambulance communication system wins Cleveland Clinic challenge

A prehospital communication system for incoming ambulances is the winner of the third annual New Ventures Healthcare Challenge hosted by Cleveland Clinic Innovations.

Thumbnail

Leapfrog: Patient safety improvements are hit-and-miss

The Leapfrog Group's annual Hospital Safety Scores indicate that improvements in patient safety remain elusive. 

Thumbnail

Patient portal study finds disparities in vulnerable populations

The more digital health tools are adopted, the greater the disparities among at-risk populations, according to a study published in the Clinical Journal of the American Society of Nephrology.

Thumbnail

HIMSS, AHIMA, IHE collaboration produces guide for interoperability standards development

HIMSS, AHIMA and IHE have banded together to produce a report that's meant to serve as a guide for those working on developing interoperability standards. 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.